Fábio B.

QNTXneuro’s purpose is to decrease the cost of recruitment for clinical trials. As a potential participant moves along in the clinical trial funnel, the tests become more expensive and invasive. We developed a mobile-first web app which uses well-established cognition verbal tests, in combination with a tailored ML algorithm to let the trial manager know whether it is advisable to continue the process with a participant or not. My focus was everything technology related, dev-ops full stack.Technology-wise we leveraged Terraform to auto-deploy the entire AWS stack from a git branch. This allowed us to iterate fast over the upcoming features without having to fully merge them into main.

While at Biogen, I was part of a multi-disciplinary team responsible for the neurodiem product. My role as a technical manager and software architect consisted of constant alignment with the business and content stakeholders, in terms of how to bring new features to an ongoing project, which is developed by an external company. Neurodiem is deployed in more than 35 countries, which comes with additional complexity for upholding local regulations. Neurodiem also has an app store presence for both Android and iOS, developed by yet a different third party. Constant alignment was the key to success, and I played a role in these alignment efforts.